156 related articles for article (PubMed ID: 11241914)
21. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.
Maurer CA; Z'Graggen K; Renzulli P; Schilling MK; Netzer P; Büchler MW
Br J Surg; 2001 Nov; 88(11):1501-5. PubMed ID: 11683749
[TBL] [Abstract][Full Text] [Related]
22. Results after change of treatment policy for rectal cancer--report from a single hospital in China.
Wu AW; Gu J; Wang J; Ye SW; An Q; Yao YF; Zhan TC
Eur J Surg Oncol; 2007 Aug; 33(6):718-23. PubMed ID: 17240113
[TBL] [Abstract][Full Text] [Related]
23. Controversies in the surgical management of rectal cancer.
Kane JM; Petrelli NJ
Semin Radiat Oncol; 2003 Oct; 13(4):403-18. PubMed ID: 14586830
[TBL] [Abstract][Full Text] [Related]
24. Is intraoperative neuromonitoring associated with better functional outcome in patients undergoing open TME? Results of a case-control study.
Kneist W; Kauff DW; Juhre V; Hoffmann KP; Lang H
Eur J Surg Oncol; 2013 Sep; 39(9):994-9. PubMed ID: 23810330
[TBL] [Abstract][Full Text] [Related]
25. [Total mesorectal excision by laparoscopy for rectal cancer].
Leroy J; Arenas M; Marescaux J
Rev Gastroenterol Mex; 2004 Aug; 69 Suppl 1():73-83. PubMed ID: 15757150
[TBL] [Abstract][Full Text] [Related]
26. [Postoperative complications of curative treatment for rectal cancer in males with sphincter-preserving total mesorectal excision].
Szynglarewicz B; Matkowski R; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z
Pol Merkur Lekarski; 2007 Nov; 23(137):348-51. PubMed ID: 18361317
[TBL] [Abstract][Full Text] [Related]
27. Increased rate change over time of a sphincter-saving procedure for lower rectal cancer.
Wu XJ; Wang JP; Wang L; He XS; Zou YF; Lian L; Zhang LJ; Lan P
Chin Med J (Engl); 2008 Apr; 121(7):636-9. PubMed ID: 18466685
[TBL] [Abstract][Full Text] [Related]
28. Experience of surgery for rectal cancer with total mesorectal excision in a general surgical practice.
Dowdall JF; Maguire D; McAnena OJ
Br J Surg; 2002 Aug; 89(8):1014-9. PubMed ID: 12153627
[TBL] [Abstract][Full Text] [Related]
29. [Current problems of the surgical treatment of rectal cancer: analysis of the literature and personal experience].
Lombari C; Formisano V; Iannucci A; Alderisio A; Sarno A; Bucci G; Lombari P
Chir Ital; 2001; 53(4):543-9. PubMed ID: 11586574
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
[TBL] [Abstract][Full Text] [Related]
31. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
32. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
33. [Rectal cancer--review of methods and treatment results].
Grotowski M
Pol Merkur Lekarski; 2004 Mar; 16(93):289-92. PubMed ID: 15190612
[TBL] [Abstract][Full Text] [Related]
34. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer.
Akasu T; Sugihara K; Moriya Y
Ann Surg Oncol; 2009 Oct; 16(10):2779-86. PubMed ID: 19626377
[TBL] [Abstract][Full Text] [Related]
35. Lateral pelvic lymphadenectomy and total nerve sparing for locally advanced rectal cancer in Western patients.
Di Matteo G; Peparini N; Maturo A; Di Matteo FM; Zeri KP; Redler A; Mascagni D
Panminerva Med; 2001 Jun; 43(2):95-101. PubMed ID: 11449179
[TBL] [Abstract][Full Text] [Related]
36. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer.
Enker WE; Havenga K; Polyak T; Thaler H; Cranor M
World J Surg; 1997 Sep; 21(7):715-20. PubMed ID: 9276702
[TBL] [Abstract][Full Text] [Related]
37. Current surgical management of rectal cancer.
Kusunoki M; Inoue Y
Dig Surg; 2007; 24(2):115-9. PubMed ID: 17446705
[TBL] [Abstract][Full Text] [Related]
38. Lymph node dissection in rectal carcinoma: TME and what else?
Göhl J; Hohenberger W; Merkel S
Onkologie; 2009 Feb; 32(1-2):57-61. PubMed ID: 19209023
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of bipolar scissors for rectal cancer surgery with autonomic nerve preservation.
Karube H; Masuda H; Takayama T
Hepatogastroenterology; 2004; 51(58):990-3. PubMed ID: 15239231
[TBL] [Abstract][Full Text] [Related]
40. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
